Estados Unidos · Prensa financiera · Investor's Business Daily

Merck Beats, But Can Shares Outplay The Cancer Vaccine News?

Publicado por Investor's Business Daily · Estados Unidos hace 1 h

Dow Jones component Merck hiked its 2026 outlook Thursday on the back of a solid third-quarter report that included a notable Keytruda beat. The post Merck Beats, But Can Shares…

Leer el artículo completo en Investor's Business Daily Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.investors.com)

Merck Beats, But Can Shares Outplay The Cancer Vaccine News?

También te puede interesar

Oil Is Gushing Out of the Gulf. Why Are Prices Still Above $100 a Barrel?

Reddit’s AI Traffic Loss Still in Focus as Earnings Approach

Merck Beats, But Can Shares Outplay The Cancer Vaccine News?

Compartir

También te puede interesar

Oil Is Gushing Out of the Gulf. Why Are Prices Still Above $100 a Barrel?

Reddit’s AI Traffic Loss Still in Focus as Earnings Approach